Hartfalen: epidemiologie, risicofactoren en toekomst

RIVM Rapport 260401006
Najafi F, Jamrozik K, Dobson AJ (2009). Understanding the ‘epidemic of heart
failure’: a systematic review of trends in determinants of heart failure. Eur J
Heart Fail 11: 472-9.
Nakamura M, Tanaka F, Yonezawa S, Satou K, Nagano M, Hiramori K (2003).
The limited value of plasma B-type natriuretic peptide for screening for left
ventricular hypertrophy among hypertensive patients. Am J Hypertens 16,
1025-9.
Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA (2009).
Cardiac mechanics in mild hypertensive heart disease: a speckle-strain
imaging study. Circ Cardiovasc Imaging 2, 382-90.
Neumann T, Biermann J, Erbel R, Neumann A, Wasem J, Ertl G, Dietz R (2009).
Heart failure: the commonest reason for hospital admission in Germany:
medical and economic perspectives. Dtsch Arztebl Int 106, 269-75.
Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004). The incidence of
congestive heart failure in type 2 diabetes: an update. Diabetes Care 27,
1879-84.
Nicklas BJ, Cesari M, Penninx BW, Kritchevsky SB, Ding J, Newman A, Kitzman
DW, Kanaya AM, Pahor M, Harris TB (2006). Abdominal obesity is an
independent risk factor for chronic heart failure in older people. J Am Geriatr
Soc 54, 413-20.
Niemann B, Chen Y, Teschner M, Li L, Silber RE, Rohrbach S (2011). Obesity
induces signs of premature cardiac aging in younger patients: the role of
mitochondria. J Am Coll Cardiol 57, 577-85.
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M
(2006). Burden of valvular heart diseases: a population-based study. Lancet
368, 1005-11.
Okin PM, Devereux RB, Kjeldsen SE, Edelman JM, Dahlof B (2009). Incidence of
heart failure in relation to QRS duration during antihypertensive therapy: the
LIFE study. J Hypertens 27, 2271-7.
Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa
P (1995). Gender differences and aging: effects on the human heart. J Am
Coll Cardiol 26, 1068-79.
Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE,
Devereux RB, Dahlof B, Hildebrandt PR (2006). N-terminal brain natriuretic
peptide predicted cardiovascular events stronger than high-sensitivity Creactive
protein in hypertension: a LIFE substudy. J Hypertens 24, 1531-9.
Opasich C, Tavazzi L, Lucci D, Gorini M, Albanese MC, Cacciatore G, Maggioni AP
(2000). Comparison of one-year outcome in women versus men with chronic
congestive heart failure. Am J Cardiol 86, 353-7.
Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA (2006). Controversies in
ventricular remodelling. Lancet 367: 356-67.
Paget V, Legedz L, Gaudebout N, Girerd N, Bricca G, Milon H, Vincent M,
Lantelme P (2011). N-terminal pro-brain natriuretic peptide: a powerful
predictor of mortality in hypertension. Hypertension 57, 702-9.
Palmieri L, Bennett K, Giampaoli S, Capewell S (2010). Explaining the decrease
in coronary heart disease mortality in Italy between 1980 and 2000. Am J
Public Health 100: 684-92.
Parikh NI, Gona P, Larson MG, Fox CS, Benjamin EJ, Murabito JM, O'donnell CJ,
Vasan RS, Levy D (2009). Long-term trends in myocardial infarction
incidence and case fatality in the National Heart, Lung, and Blood Institute's
Framingham Heart study. Circulation 119, 1203-10.
Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers
FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A, Edes
I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG,
Brutsaert DL (2007). How to diagnose diastolic heart failure: a consensus
Pagina 109 van 122